In a hopeful sign for the health of the nation’s brains, the percentage of American seniors with dementia is dropping, a new study finds. The downward trend has emerged despite something else the study shows: a rising tide of three factors that are thought to raise dementia risk. Those with the most years of education had the lowest chances of developing dementia.
The U.S. National Institutes of Health will award an estimated $9 million over the next 5 years to a new statewide center to enhance the understanding and treatment of Alzheimer’s disease and related dementias.
Doctors write millions of prescriptions a year for drugs to calm the behavior of people with Alzheimer’s disease and other types of dementia. But non-drug approaches actually work better, and carry far fewer risks, experts conclude in a new report.
For up to one in five Americans over age 65, getting older brings mild memory and thinking problems – what doctors call mild cognitive impairment, or MCI. Now, a pair of U-M doctors has put together a definitive look at what works, and what doesn’t, when it comes to this common condition.
A new approach to handling agitation, aggression and other unwanted behaviors by people with dementia may help reduce the use of psychiatric drugs in this population, and make life easier for them and their caregivers
The first published results from an early-stage clinical trial show that spinal cord stem cells can be delivered safely into the spines of patients with the condition commonly known as Lou Gehrig's disease, opening the door for further research on this innovative approach.
A University of Michigan study shows promise for developing protein therapies for disease prevention. A computer analysis by two University of Michigan researchers may lead to development of therapies for some major diseases by rescuing proteins that have stopped performing normally. The U-M findings appear as a cover story in the April 2011 issue of Biophysical Journal.